Search clinical trials for: HER2 ,
Total 2786 results
-
University of Alabama at BirminghamRecruitingHER2-positive Breast CancerUnited States
-
King's College LondonGuy's and St Thomas' NHS Foundation Trust; Brighton and Sussex University Hospitals...Recruiting
-
xuexin heNot yet recruitingHER2-positive Breast Cancer
-
NSABP Foundation IncGenentech, Inc.; Celcuity, LLCRecruitingHER2-negative Breast CancerUnited States
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLC; Breast Cancer Research FoundationActive, not recruitingBreast Cancer | HER2-positive Breast CancerUnited States
-
Seagen Inc.Active, not recruitingHER2 Positive Breast CancerUnited States
-
Fox Chase Cancer CenterGenentech, Inc.Active, not recruitingHER2-positive Breast CancerUnited States
-
Zhejiang Hisun Pharmaceutical Co. Ltd.Completed
-
Fondazione Policlinico Universitario Agostino Gemelli...Active, not recruiting
-
BeiGeneCompletedHER2-negative Breast CancerChina
-
Alteogen, Inc.CompletedHER2-positive Breast CancerKorea, Republic of
-
NSABP Foundation IncEisai Inc.CompletedBreast Cancer | HER2-negative Breast CancerUnited States, Canada
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHER2-positive Breast CancerChina
-
Biyun Wang, MDCompleted
-
Sichuan Provincial People's HospitalUnknownHER2-negative Breast CancerChina
-
Guangdong Provincial People's HospitalCompletedHER2-Positive Breast CancerChina
-
Sun Yat-sen UniversityCompletedHER2 Positive Breast CancerChina
-
Guangdong Provincial People's HospitalUnknownHER2-Positive Breast CancerChina
-
Anhui Provincial HospitalUnknownHER2 Positive Breast Carcinoma
-
Shandong UniversityUnknownHER2-positive Breast Cancer
-
Yale UniversityGenentech, Inc.CompletedHer2-Positive Breast CancerUnited States
-
Youzhi ZhuRecruitingBreast Cancer FemaleChina
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingUnresectable Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Metastatic Breast Adenocarcinoma | Metastatic HER2-Positive Breast Carcinoma | Recurrent Breast Adenocarcinoma | Recurrent HER2-Positive Breast Carcinoma | Unresectable HER2-Positive Breast CarcinomaUnited States, Canada
-
Prof. Wolfgang JanniCompletedHER2-negative and Hormone-receptor Positive Metastatic Breast Cancer | HER2-negative Circulating Tumor Cells | Postmenopausal Female PatientsGermany
-
RemeGen Co., Ltd.RecruitingGynecological MalignancyChina
-
Lucia Del Mastro,MDCompleted
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingNon-squamous NSCLC | HER2 Exon 20 MutationKorea, Republic of, United States, Taiwan, Belgium, Spain, China, Australia, Turkey, Italy, France, Germany, Poland, Russian Federation
-
Spectrum Pharmaceuticals, IncTerminatedNSCLCUnited States, Canada, Netherlands, Belgium, Israel, Spain, France, Italy
-
Nancy Lin, MDGlaxoSmithKline; NovartisActive, not recruitingBreast CancerUnited States
-
Nantes University HospitalInstitut National de la Santé Et de la Recherche Médicale, France; Gilead SciencesCompletedHER2 Negative Breast Carcinoma Expressing CEAFrance
-
AgendiaCompleted
-
Alteogen, Inc.Cristália Produtos Químicos Farmacêuticos Ltda.Completed
-
Baylor Breast Care CenterAstraZenecaTerminated
-
Fudan UniversityUnknown
-
AIO-Studien-gGmbHRoche Pharma AGCompletedAdenocarcinoma of the Gastroesophageal Junction | Adenocarcinoma of the StomachGermany
-
N.N. Petrov National Medical Research Center of...RecruitingOligometastatic Disease | HER2-positive Metastatic Breast CancerRussian Federation
-
HiberCell, Inc.Merck Sharp & Dohme LLCCompletedMalignant Neoplasm of BreastUnited States
-
Jungsil RoPfizer; HK inno.N CorporationCompletedBreast CancerKorea, Republic of
-
Jungsil RoCompletedBreast CancerKorea, Republic of
-
Samsung Medical CenterRecruitingHER2-positive Breast CancerKorea, Republic of
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Huashan HospitalRecruitingHER2-positive Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
Fudan UniversityNot yet recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Cancer Trials IrelandRecruitingHER2-positive Breast CancerIreland
-
Institut de cancérologie Strasbourg EuropeNot yet recruitingHER2-positive Breast Cancer
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Hunan Cancer HospitalRecruiting